Abstract: Vital sign monitoring is especially challenging in small animals, given the high metabolic rates and small volumes under consideration. An embodiment of the present invention includes a unique nose-cone design and associated instrumentation which allows for measurement of respiratory parameters, including anesthesia gas concentration, inspiratory and expiratory O2, and inspiratory and expiratory CO2 (capnometry). Such instrumentation facilitates a physiologic assessment of small animals undergoing general anesthesia, an increasingly important consideration as small animals play a greater role in in vivo biomedical studies. In addition, the techniques proposed herein are suitable for measurement on small respiratory volumes associated with neonatal monitoring.

Abstract: Methods and devices to determine rate of particle production and the size range for the particles produced for an individual are described herein. The device (10) contains a mouthpiece (12), a filter (14), a low resistance one-way valve (16), a particle counter (20) and a computer (30). Optionally, the device also contains a gas flow meter (22). The data obtained using the device can be used to determine if a formulation for reducing particle exhalation should be administered to an individual.

Abstract: A method of identifying a potential cause of pulmonary edema is provided. The method includes obtaining one or more impedance vectors between predetermined combinations of the electrodes positioned proximate the heart. At least one of the impedance vectors is representative of a thoracic fluid level. The method also includes applying a stimulation pulse to the heart and sensing cardiac signals of the heart that are representative of an electrophysiological response to the stimulation pulse. The method further includes monitoring the cardiac signals and at least one of the impedance vectors with respect to time to identify the potential cause of pulmonary edema.

Abstract: A device according to an aspect of the invention includes an air escapement conduit having an inlet port providing air communication with a chest cavity and an outlet port providing air communication with a vacuum source, the conduit allowing an air flow from the inlet port to the outlet port in response to a pressure differential between the ports, and a detector responsive to the air flow that provides a signal related to the air flow. The device may include an indicator device operable to provide evacuation information in response to the signal. The air escapement conduit may include a bubble chamber or a valving mechanism. The detector may be a pressure differential sensor operable to detect a difference in air pressure between the inlet port and the outlet port, and generate a signal related to the difference.

Abstract: Techniques are provided for detecting the circadian state of a patient using an implantable medical device based on selected blood carbon dioxide (CO2) parameters. In one example, the implantable device tracks changes in end tidal CO2 (etCO2) levels and changes in maximum variations of pCO2 levels per breathing cycle (?cycleCO2) over the course of the day and determines the circadian state based thereon. It has been found that average etCO2 levels are generally highest and average ?cycleCO2 levels are generally lowest while a patient is asleep and opposite while a patient is awake. Hence, by tracking changes in average etCO2 and ?cycleCO2 levels over the course of the day, circadian states can be detected. Minute ventilation and activity levels are used to assist in the determination of the circadian state. Additional techniques are directed to detecting the stage of sleep.

Abstract: A device according to an aspect of the invention includes an air escapement conduit having an inlet port providing air communication with a chest cavity and an outlet port providing air communication with a vacuum source, the conduit allowing an air flow from the inlet port to the outlet port in response to a pressure differential between the ports, and a detector responsive to the air flow that provides a signal related to the air flow. The device may include an indicator device operable to provide evacuation information in response to the signal. The air escapement conduit may include a bubble chamber or a valving mechanism. The detector may be a pressure differential sensor operable to detect a difference in air pressure between the inlet port and the outlet port, and generate a signal related to the difference.

Abstract: In a lung therapy method, hyperpolarized gas is administered for one breath to a subject, and a magnetic resonance scan of at least one lung of the subject is conducted. The data obtained from the scan are evaluated, specifically to determine the extent and distribution of infusion of hyperpolarized gas in the lung, as an indication of the alveolae in the lung which are open. Based on the evaluation of the data obtained in the magnetic resonance scan, a determination is made as to whether administration of a surfactant is necessary in order to improve opening of the lung. If a surfactant is administered, the procedure can be repeated to obtain an updated dataset, which can be evaluated to determine whether the administered surfactant has been effective.